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Abstract
Background: Physical inactivity is a major risk factor for nonalcoholic fatty liver disease (NAFLD). Exercise-based prevention
interventions for improving cardiorespiratory fitness are a recommended complementary treatment for NAFLD. Achievement of
minimally effective physical activity to improve cardiorespiratory fitness among patients typically involves high personal and
financial expenses in face-to-face settings. We designed an eHealth approach for patients with NAFLD to improve the
cardiorespiratory fitness and report the first results of the HELP (Hepatic Inflammation and Physical Performance in Patients
With NASH [nonalcoholic steatohepatitis]) study.
Objective: We aimed to assess the effectiveness of an 8-week, tailored, Web-based exercise intervention for cardiorespiratory
fitness improvement, expressed as peak oxygen uptake (peak volume of oxygen [VO2peak]), in patients with histologically confirmed
NAFLD.
Methods: In a 24-month period, 44 patients were enrolled into an 8-week, prospective, single-arm study with 12 weeks of
follow-up. After a medical examination and performance diagnostics, a sports therapist introduced the patients to a Web-based
platform for individualized training support. Regular individual patient feedback was provided to systematically adapt the weekly
exercise schedule, which allowed us to monitor and ensure patient adherence to strength and endurance training and optimize the
step-wise progressive exercise load. Exercise progression was based on an a priori algorithm that considered the subjective rate
for both perceived exhaustion and general physical discomfort. The VO2peak was assessed at baseline and at the end of the study
by spiroergometry.
Results: A total of 43 patients completed the intervention with no adverse events. The VO2peak increased significantly by 2.4
mL/kg/min (8.8%; 95% confidence interval [CI]: 1.48-3.27; P<.001) accompanied by a reduction of 1.0 kg in a body weight
(95% CI: 0.33-1.58; P=.004) and 1.3 kg in body fat mass (95% CI: 0.27-2.27; P=.01). In an exploratory analysis, step-wise logistic
regression analysis revealed low body fat and VO2peak at baseline and the total minutes of endurance training during the intervention
as main contributors to a positive change in VO2peak. Our predictive model indicated that the average patient with NAFLD needed
223 min for stabilization of VO2peak and 628 min for average improvement in VO2peak. However, in patients with a VO2peak
approximately 20% higher than the average VO2peak, 628 min were only sufficient to stabilize the VO2peak and >40% reduction
in the average fat mass would be required to achieve an average outcome.
Conclusions: This is the first study to show that patients with NAFLD can be effectively supported by a Web-based approach,
which can increase the VO2peak to a similar extent as face-to-face interventions. Patients with low body fat and low VO2peak
benefited the most from our intervention. In terms of future treatment strategies, NAFLD patients with high body fat may
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particularly benefit from body-fat reduction through a strict nutritional intervention, subsequently enabling a more effective
exercise intervention.
Trial Registration: ClinicalTrials.gov NCT02526732; https://clinicaltrials.gov/ct2/show/NCT02526732 (Archived by WebCite
at http://www.webcitation.org/74pXhXXfq)
International Registered Report Identifier (IRRID): RR2-10.2196/resprot.8607
(J Med Internet Res 2019;21(1):e11250)   doi:10.2196/11250
KEYWORDS
exercise; fatty liver; lifestyle; NAFLD; treatment; Web-based
Introduction
Sedentary behavior and an unhealthy diet are common in
Western industrialized countries [1,2]. Modern lifestyle increases
the risk for chronic diseases such as metabolic syndrome [2-5].
According to the Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in adults, metabolic
syndrome is defined by the presence of abdominal obesity,
hypertriglyceridemia, low high-density lipoprotein cholesterol
levels, hypertension, and impaired fasting glycemia [6]. In the
last few years, nonalcoholic fatty liver disease (NAFLD) has
gained attention, owing to its highest increase in the incidence
among chronic liver diseases worldwide [3,4,7-9]. Some
researchers consider NAFLD as a hepatic manifestation of
metabolic syndrome, whereas others consider it a consequence
of metabolic syndrome [3,10-13].
Irrespective of age and ethnicity, 20%-30% of the general
population shows fatty changes in the liver [8,11,14-17], and
the prevalence of NAFLD is higher in patients with diabetes
than in patients without diabetes [18]. NAFLD is a benign,
preliminary-stage disease with the potential to progress from
simple steatosis to nonalcoholic steatohepatitis (NASH),
cirrhosis, and finally, hepatocellular carcinoma [9,19-22]. The
pathways driving this progression are numerous and complex,
[22,23] and not every patient with NAFLD develops
cirrhosis-related complications [9,24]. However, patients with
NAFLD have a higher mortality rate than the general population
[9,24,25]. Most patients with NAFLD are asymptomatic
[16,19,26], but some experience unspecific symptoms such as
fatigue [26,27] and depression [28], which additionally affect
the health-related quality of life [29,30]. If NAFLD is left
untreated, most patients will develop diabetes in the long-term
[9]. To improve the condition of the liver and reduce additional
risk factors, changes towards a balanced nutrition and a more
physically active lifestyle are recommended in daily life
[21,26,31-34]. The Practice Guidelines of the American
Association for the Study of Liver Diseases recommends a loss
of at least 3%-5% of body weight to improve steatosis [35]. The
current recommendation for adult patients with NAFLD or
NASH is a physical activity target of at least 150 min of
moderate-intensity exercise per week or 75 min of
vigorous-intensity exercise per week [36]. In addition,
strengthening exercises should be performed twice a week [36].
Most people with NAFLD are unaware of the presence of the
disease due to the absence of any specific symptoms. Therefore,
NAFLD is occasionally self-caused [37] and develops and
progresses over years. Studies showed a reduced physical
activity level (intensity and amount) in patients with NAFLD
compared to healthy individuals [12,27,38] and a suboptimal
cardiorespiratory fitness, with <20% of patients meeting the
recommended physical activity [39]. In a survey conducted by
Kistler et al, 54% of participants were inactive, and 57% of
them did not perform any recreational activity; although the
remaining 43% performed some activity, it was not enough to
achieve the goals recommended [40]. Besides the decreased
activity level, prolonged sitting time is associated with a higher
prevalence of NAFLD [41,42]. At diagnosis, patients are
encouraged to immediately change many aspects of their daily
routine, which requires them to overcome different barriers and
obstacles; for example, time and place constraints are common
hurdles in maintaining regular activity [4,37,43,44]. Changing
one’s lifestyle is not easy, especially for patients with highly
sedentary habits [45]. Consequently, regular motivational
support from experts is needed [45]. Thus, advances in modern
technologies should be considered for promoting
health-conscious behavior [43]. A survey conducted by the Pew
Research Center in 2015 showed that 84% of American adults
have access to a computer and regularly use the internet [46].
In 2005, 75% of internet users searched for health information,
and 42% of them searched for specific information about
exercise and training [47]. The possibility to reach and support
large numbers of patients via the internet [48] can thus be a
cost-effective way to improve and maintain an active lifestyle
[49]. Further, frequent issues like time and place constraints for
joint exercise could be neglected with an eHealth approach.
Web-based interventions with cancer patients were the first to
report promising results [50,51]. The aim of our prospective,
non-randomized, pilot study was to determine whether online
support aids patients with NAFLD or NASH in establishing and
maintaining a regular level of physical activity and whether
individualized training recommendations improve the overall
physical fitness determined by the peak oxygen uptake (peak
volume of oxygen [VO2peak]) and body composition.
Methods
Participants
The HELP (Hepatic Inflammation and Physical Performance
in Patients With NASH) study is a prospective, single-arm study
in patients with histologically confirmed NAFLD and explored
the feasibility and effectivity of an individualized exercise
intervention. A total of 46 patients were recruited from August
2015 to December 2017. The study was registered at
ClinicalTrials.gov (NCT02526732).
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Before the study was initiated, a focus group was conducted at
the Department of Sports Medicine. The team of experts tested
the website over a period of 4 weeks. During this time, the
distribution of roles, usability, and communication features were
tested and revised. No changes in structure or content were
made during the trial period. All study participants were
monitored and supported by the same sports therapist. A 24-hour
turn-around time was mandated for responses to requests from
the participants.
The inclusion criteria were age of 18-70 years and histologically
proven NAFLD. Subjects were excluded if they had bariatric
operation in the past 5 years; body mass index (BMI) <18.5
kg/m2 or >45 kg/m2; instable coronary heart disease; coronary
interventions in the past 6 months; stroke in the past 6 months;
high-grade coronary artery disease (II-IV); chronic obstructive
pulmonary disease; renal or metabolic abnormalities;
uncontrolled hypertension; other liver diseases such as hepatitis;
decompensated liver cirrhosis; hepatocellular carcinoma; alcohol
consumption >30 g/day in men and >20 g/day in women;
pregnancy; medications that can cause secondary NASH, such
as corticosteroids; other immunological or inflammatory diseases
(eg, systemic lupus erythematosus); musculoskeletal disorders;
and phenprocoumon therapy.
Study Design
The primary outcome was defined as a change in the VO2peak
from the baseline. The secondary outcome measures included
changes in body composition, lung function, and changes in
performance parameters from the cardiopulmonary exercise
test. Assessment of the primary and secondary outcomes was
performed before and after the 8-week intervention. Particular
attention was paid to the acceptance and safety of the Web-based
support concept. From a physical intervention point of view,
acceptance of the concept was assessed by the performed
exercise recommendations, where completion of 80% of the
recommended exercises indicated good adherence. Considering
that this was an eHealth approach, acceptance was assessed on
the basis of user behavior and consequent weekly feedback.
Safety was assessed by the occurrence of overloading or injuries.
Patients underwent physical examinations, laboratory tests, and
an ultrasound prior to inclusion in the study. After providing
informed consent, the patients performed a cardiopulmonary
exercise test until exhaustion at the Department of Sports
Medicine, University Mainz. In addition, the body composition
was measured using a bio-impedance analyzer (InBody 3.0;
Biospace, Seoul, South Korea). A standard 12-lead resting
electrocardiogram and a pulmonary function test (spirometry
by Body Box 5500; Medisoft, Sorinnes, Belgium) were also
performed. Further details about the testing procedure are
extensively described elsewhere [52,53]. After the exercise test,
each patient was registered and trained by the administrator on
the webpage. The registration and explanation process took
approximately 1 hour. A detailed explanation, a manual for the
homepage, a heart rate monitor, and three elastic tapes were
provided to each patient. A detailed illustration on the
measurements is available as a video clip in Multimedia
Appendix 1. All patients underwent the abovementioned clinical
and sports medical examinations at the start of the study and
after 8 weeks of the intervention. The clinical examination was
additionally performed 12 weeks after the end of the intervention
(Figure 1).
Intervention
Patients received tailored exercise recommendations via internal
messages on the system on a weekly basis [53]. Depending on
the initial exercise test and the subjective feedback from the
patients during the intervention period of 8 weeks, the exercise
program was adjusted for each patient, considering the American
College of Sports Medicine’s guidelines for exercise testing
and prescription [54]. To avoid early dropouts,
moderate-intensity exercise for 3 sessions per week was chosen
(endurance training twice [walking or running] and strength
training once [major muscle groups]). The program was
intensified after a 4-week familiarization to reach a frequency
of 5 sessions per week (endurance training thrice and strength
training twice) for the remaining 4 weeks.
Figure 1. Study flow chart.
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In addition to the frequent interaction with a counselor, peer
support is considered a cornerstone in this Web-based concept.
Therefore, a discussion board and a chatroom were established
to improve social support and adherence [55]. However, due to
issues in data-protection regulations and the ethics protocol,
activities were not controlled, stored, or analyzed.
Strength Training
A program of 10 strength exercises was carried out in a
prescribed sequence to stimulate muscular strength in the major
muscle groups. Detailed illustrated instruction and video files
for the exercises were available on the website. Training
individualization was achieved by varying the number of
repetitions or number of sets.
Endurance Training
The individualized endurance training program was based on
lactate measurements. The intensity of the jogging program was
controlled by a heart rate monitor (FT1; Polar, Kempele,
Finland). After an initial continuous method with a heart rate
at the lactate threshold, the training followed the interval method
(eg, 2 x 4 min, 2 x 3 min, 2 x 2 min with 2-min rest) at a higher
heart rate. The intended intensity of training was achieved by
adjusting the interval time or adding additional intervals.
Training Progress
Endurance training and strength training, consisting of
bodyweight exercises and exercises with elastic tapes, were the
main content of the training recommendations. Each training
started with a 5-min warm up and was followed by a 5-min
cool-down phase. A selection of relaxation and breathing
exercises was also available on the website. At the end of each
week, the patients sent in a filled schedule with important
information such as average heart rate, resting heart rate, and
training time. In addition, the following parameters were
assessed to allow modification of the training intensity and
duration for the following week: (1) The patient’s individual
assessment of pain and training load using the modified Borg
scale (score range, 1-10) [56] after each training session, and
(2) the traffic light principle to regulate the intensity of the next
week’s training. Depending on individual feedback, an increase
or decrease in the training recommendations was possible,
wherein the pain value was dominant for the decision [53]. The
weekly feedback ensured appropriate load according to
individual abilities and assessment of compliance. In addition,
group training was offered biweekly at the sports center of the
University Mainz.
Statistical Procedures
Statistical analysis was performed using SPSS Statistics, version
23 (IBM Corp., Armonk, NY), and JMP (SAS Institute,
Cary, NC). Descriptive statistics were used for presenting
baseline characteristics and the user behavior of the website.
Variables were described using mean, median, and SD. Normal
distribution was tested using the Shapiro-Wilk test due to the
small sample size. In case of normal distribution, the paired
student t test was used to determine within-group differences
before and after (at 8 weeks) the intervention. Intention-to-treat
analysis was performed, and the data were processed according
to the last observation carried forward method. A P value <.05
was considered statistically significant.
For investigation of factors that contribute to changes in VO2peak,
we employed a two-step procedure. We first computed a
step-wise feed-forward logistic regression analysis. To ensure
stringent inclusion criteria, we fed the model with the baseline
data on anthropometrics, including body composition and
performance data (Table 1), and data on endurance training (for
8 weeks) and the total exercise time (strength and endurance
training in minutes for 8 weeks). Only 3 factors reached a
significance level set at .05 for entering a single variable into
the regression equation. These factors were then used to compute
a logistic regression analysis. Fold-change in VO2peak was
normalized by a normalization procedure using the inverse of
the squared values, as suggested by Box-Cox analysis.
Results
Baseline Characteristics
A total of 46 patients were screened. After exclusion of 2
patients, 44 patients were finally included in the study (Figure
2). One patient dropped out (2.3%) during the intervention
period.
With regard to the weight status, 3 (6.8%) patients had a normal
weight status, 15 (34.1%) were overweight, and 26 (59.1%)
were obese. All patient characteristics at the baseline are
summarized in Table 1. The mean age of all patients was 42
(SD 10.9) years. Of the 44 patients, 41 (93.2%) had a BMI >25
kg/m² and >27% percent of body fat, and the mean BMI of all
patients was 31.2 (SD 4.3) kg/m². In total, 1169 exercise
recommendations (730 endurance and 439 strength) were
performed, and 207 recommended workouts were cancelled
due to different reasons.
Primary Outcome
At baseline, the mean VO2peak was 27.2 mL/kg/min. After the
intervention, the VO2peak significantly increased by 8.8% (from
27.2 mL/kg/min [SD 5.1] to 29.6 mL/kg/min [SD 5.4]; 95% CI:
–3.27 to –1.48; P<.001; Figure 3).
We employed logistic regression analysis to assess the combined
effects of the variables shown in Table 1 on the fold change in
the maximum volume of oxygen (VO2max) by step-wise
feed-forward logistic regression analysis. A multiple linear
regression model with 3 independent predictors emerged on the
basis of 43 total observations (df=3; F=8.03; r2=0.38; P<.001).
All predictors had a significant influence and a corrected power
of >80% with VO2peak at baseline (t=–3,77; standard effect
size=–0.12; 95% CI: –0.18 to –0.05; P<.001), total minutes of
endurance training during the intervention period (t=3.27;
standard effect size=0.09; 95% CI: 0.04-0.15; P=.002), and
body fat (%) at baseline (t=–3.22; standard effect size=–0.10;
95% CI: –0.17 to –0,04; P=.003). The model indicated that
participants in the program with average body fat percentage
(27.9%) and average VO2peak at baseline (27.1 mL/kg/min)
would need approximately 223 minutes of training within the
intervention period to maintain their baseline VO2peak (Figure
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4a), but 628 minutes of training were required to reach the
average improvement of basal VO2peak of approximately 8%
(Figure 4b). However, a high VO2peak at baseline with the
average fat mass would lead to a significantly lower outcome
(Figure 4c) that could, in principle, be compensated by low fat
mass with high baseline VO2peak (Figure 4d).
Figure 2. Patient flow chart.
Table 1. Baseline characteristics of patients enrolled in the HELP study (N=44).
ValuesCharacteristics
Age (years), n (%)
5 (11.4)<30
38 (86.4)30-60
1 (2.3)>60
30 (68.2)Male, n (%)
175 (10.3)Height (cm), mean (SD)
95.9 (17.4)Weight (kg), mean (SD)
BMIa (kg/m²), n (%)
15 (34.1)Overweight (30< BMI >25)
26 (59.1)Obese (BMI >30)
Body composition, mean (SD)
26.7 (8.2)Body fat (kg)
27.9 (7.4)Body fat (%)
64.8 (14.1)Lean body mass (kg)
Spirometry, mean (SD)
107.5 (13.3)Forced vital capacity (% norm)
96.3 (16.3)Forced expiratory volume (% norm)
Spiroergometry, mean (SD)
79 (10.2)Resting heart rate (bpm)
27.2 (5.1)VO2peak
b (mL/kg/min)
135.1 (42.9)Watt max
96.1 (21.5)Watt individual anaerobic threshold
18.5 (1.5)Borg value max score (range, 6-20)c, mean (SD)
172 (16)Heart frequency max, mean (SD)
aBMI: body mass index.
bVO2peak: peak volume of oxygen.
cThe full Borg Scale (score range, 6-20) was used for the cardiopulmonary exercise test.
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Figure 3. Individual changes in VO2peak from baseline to end of the study. VO2peak improved by 2.4 mL/kg/min.
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Figure 4. Predictive analysis for fold-change in VO2max. (a) According to this model, 222 min of endurance training is needed to stabilize VO2max in
the collective for a person with an average VO2peak of 27 mL/kg/min and average body fat of 27.9%. (b) For an improvement of approximately 8%
VO2max, an endurance training load of at least 600 min over 8 weeks is necessary. (c) A higher initial VO2peak leads to a reduced effect of the 628 min
of endurance training within 8 weeks on the primary outcome, VO2max. (d) In principal, lower body fat (%) could compensate for a higher VO2peak at
baseline (33.67 mL/kg/min) and yield an 8% improvement in VO2max with the same training load. Solid black regression lines indicate the linear effect
of VO2peak at the start of the study, total minutes of endurance training during the intervention period of 8 weeks, and body fat percentage at the start
of the study. Dashed blue lines indicate the respective upper and lower 95% confidence intervals for the regressions. *FC: Fold-change. **VO2max:
maximum volume of oxygen. ***VO2peak: peak volume of oxygen. ****Pre: before the study.
Secondary Outcomes
Significant changes were observed in body weight and BMI
(95% CI: 0.33-1.58; P=.004 and 95% CI: 0.14-0.54; P=.001,
respectively). With regard to the body composition, there was
a significant reduction in body fat (95% CI: 0.27-2.27; P=.01);
a consequent reduction in the percentage of body fat (95% CI:
0.26-2.11; P=.01); and a slight, but not significant, increase in
lean body mass (95% CI: –1.39 to 0.46; P=.31; Table 2). There
was a trend towards a low resting heart rate (95% CI: –0.18 to
7.22; P=.06), but this result was not statistically significant.
Further, no changes in lung function, expressed as forced
expiratory volume (95% CI: –4.11 to 1.38; P=.32) and vital
capacity (95% CI: –1.09 to 3.41; P=.31), were observed.
Significant changes in the power, expressed as Watt max (95%
CI: –18.46 to –10.17; P<.001) and Watt at the individual
anaerobic threshold (95% CI: –7.00 to –2.05; P=.001) were
observed (Figure 5). The maximum heart frequency remained
unchanged, and the subjective perception of exhaustion,
expressed as the Borg value, decreased significantly from
baseline to the end point of the study (95% CI: –0.05 to 0.95;
P=.02; Table 2).
Acceptance of the Program From an EHealth
Perspective
During the intervention period, regular communication and
feedback were easily achieved using the webpage. In some
cases, the patients did not send the exercise feedback on time.
Therefore, 2.8 (SD 3.8) reminders were sent to the participants
to ask for the exercise feedback. The user behavior in terms of
log-in duration and frequency is presented in Table 3. The
participants’ average length of a visit was approximately 12
min, and the average login frequency was 13 times during the
intervention period.
The typical expected attrition in registration frequency and
duration [57] was observed in this trial (Figures 6 and 7).
Nevertheless, a timely response was achieved, even in patients
who did not continue to use the webpage, by interacting via
conventional email (Table 3).
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Table 2. Study results (N=44).
P valueDifference (%)After the study, mean (SD)Baseline, mean (SD)Characteristics
0.0040.9 (0.9)95.0 (17.8)95.9 (17.4)Weight (kg)
0.0010.4 (1.3)30.8 (4.4)31.2 (4.3)BMIa (kg/m²)
—c1 (6.7)14 (32.6)b15 (34.1)bOverweight (30< BMI >25) 
—0 (0)26 (59.1)b26 (59.1)bObese (BMI >30) 
    Body composition
0.011.2 (4.5)25.5 (9.0)26.7 (8.2)Body fat (kg) 
0.011.1 (3.9)26.8 (8.4)27.9 (7.4)Body fat (%) 
0.310.4 (0.6)65.2 (14.2)64.8 (14.1)Lean body mass (kg) 
    Spirometry
0.311.2 (1.1)106.3 (14.2)107.5 (13.3)Forced vital capacity (% norm) 
0.321.3 (1.3)97.6 (13.3)96.3 (16.3)Forced expiratory volume (% norm) 
    Spiroergometry
0.064 (5)75 (11.5)79 (10.2)Resting heart rate (bpm) 
<0.0012.4 (8.8)29.6 (5.4)27.2 (5.1)VO2peak
d (mL/kg/min) 
<0.00114.4 (10.7)149.5 (49.5)135.1 (42.9)Watt max 
0.0014.5 (4.7)100.6 (24.6)96.1 (21.5)Watt individual anaerobic threshold 
0.030.5 (2.7)18 (1.8)18.5 (1.5)Borg value max (range, 6-20)e 
—0 (0)172 (14.8)172 (16)Heart frequency (max) 
aBMI: body mass index.
bValues are n (%) rather than mean (SD).
cNot applicable.
dVO2peak: peak volume of oxygen.
eThe full Borg Scale (score range, 1-10) was used for the cardiopulmonary exercise test.
Figure 5. Fold changes for maximum Watt, maximum volume of oxygen (VO2max, body fat, and Watt at the individual anaerobic threshold (IAT).
Error bars indicate 95% confidence intervals.
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Table 3. User behavior for the homepage during the intervention period (N=43).
RangeMean (SD)SumCharacteristics
3-3813.0 (8.0)557Total number of logins
16-367152.3 (93.8)6548Total login duration (min)
0-182.8 (3.8)120Total number of reminders
0-83.8 (3.7)165Use of email instead of the website for exercise feedback, n
Figure 6. Login frequency during the intervention period of 8 weeks. Error bars indicate 95% confidence intervals.
Figure 7. Login duration in minutes during the intervention period of 8 weeks. Error bars indicate 95% confidence intervals.
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Figure 8. Development of the physical activity level, expressed as weekly endurance training in minutes. The dashed line indicates the recommended
vigorous activity goal of 75 min per week by the World Health Organization. Error bars indicate 95% confidence intervals.
Table 4. Exercise profile (N=43).
RangeMean (SD)SumCharacteristics
568-18011218 (330.0)52373Total physical activity within 8 weeks (min)
173-1118677 (220.2)29104Endurance training within 8 weeks (min)
0-174.81 (5.1)207Interruption of exercise training, n
0-131.7 (2.8)72Additional workouts, n
Acceptance of the Program From a Physical
Intervention Point of View
The online exercise concept was well accepted by the patients.
The physical activity level increased steadily over the period of
8 weeks (Figure 8). After an initial familiarization period, the
exercise recommendations increased progressively. In the second
half of the intervention, the patients reached and exceeded the
activity recommended by the World Health Organization [58].
The study participants performed 72 additional workouts (eg,
hiking or playing volleyball or badminton; Table 4). However,
the participants were not obliged to record other leisure time
activities, and therefore, the additional exercises were not further
examined. The adherence to the Web-based exercise concept,
expressed as ≥80% of the endurance workouts, was good: 32
participants (74%) performed ≥80% of the recommended
endurance workouts. Training interruptions were either
documented in the weekly exercise schedule or in reply to a
request from the sports therapist. Common reasons for breaks
were deadlines (eg, congress participation or workshops),
medical reasons (eg, cold, inflammation, blisters, headache, or
food poisoning), external conditions (eg, high temperature or
heavy rain), or private reasons.
Safety
The intervention in this group of patients with liver disease was
safe. No serious adverse events occurred during the study period.
Our traffic light principle for exercise modification protected
the participants against overload. The weekly communication
between the participant and the sports therapist was essential
for the tailored feedback [53]. Neither the patients nor the
attending physician reported injuries, physical overload, or
serious concerns about the health status during the intervention
period. Notably, due to physical discomfort, 2 patients had to
be assigned to bicycle exercise instead of the prescribed exercise.
Discussion
Overview
Current guidelines recommend lifestyle changes as the primary
approach for treating obesity and NAFLD; however, only a few
studies have focused on physical activity, and neither the type
nor the intensity of appropriate exercise has been defined for
NAFLD. In addition, it has been suggested that physical
deconditioning of patients with NAFLD leads to the inability
to adhere to exercise recommendations [12,38,39]. The HELP
study explored the feasibility and efficiency of a Web-based
and patient-centered exercise support concept.
The Role of Weight Loss
Weight loss is a major goal in the treatment of NAFLD [59].
The guidelines and experts in the field recommend a weight
loss of at least 3%-5% to improve steatosis [35,60]. However,
there are critical limits to the weight loss [61]: A weight loss of
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1.6 kg per week should not be exceeded, as it could potentially
provoke portal inflammation or portal fibrosis [60,61]. In our
study, 3 patients showed a normal weight status; therefore,
weight reduction was not needed. The term weight management
is more accurate than weight loss in this context. We found a
significant, but extremely low, weight change among the
patients, which is in accordance with the findings of other
exercise studies [62-64]. Weight gain is a result of a high energy
intake and low energy expenditure [65]. Weight reduction is
only possible if the energy expenditure persistently exceeds the
energy intake [31]. Therefore, diet is a necessary aspect of
weight reduction. Furthermore, our prediction model showed
that a reduction in the fat mass percentage is crucial to
significantly improve cardiorespiratory fitness with achievable
physical activity. Regular exercise supports energy expenditure,
but conscious nutrition is essential for control of energy intake.
Moreover, the absence of weight loss might partly be explained
by a moderate shift from fat mass to fat-free mass. Regular
activity reduces body fat and increases lean body mass. Another
explanation for not observing weight loss during the intervention
is insufficient negative energy balance due to a low starting
intensity [66]. For effective weight loss, a longer duration and
increased intensity of exercise is required. Nevertheless, exercise
studies show promising results in terms of decreased insulin
and homeostasis model assessment index [63,67], improved
cardiorespiratory fitness [62,68], reduced hepatic and visceral
lipid levels [63,69], reduced liver enzyme levels, and modulated
liver fat content [34], irrespective of the nutrition intake.
Exercise combined with an adjusted diet shows strong effects
on weight change, but exercise also has independent modes of
action. Thus, physical activity or structured exercise
recommendations should be strongly promoted due to their
additional benefits in the absence of weight loss.
Fitness Improvement
Takahashi et al (2015) assessed the efficiency and safety of two
simple resistance exercises in 53 patients with NAFLD [67].
After a 12-week period, patients in the intervention group had
a significantly increased mean fat-free mass (–0.24 [SD 0.88]
vs 0.30 [SD 0.67] kg; P=.01) and muscle (–0.24 [SD 0.82] vs
0.25 [SD 0.70] kg; P=.02) compared to the control group [67],
which are in line with our findings. Another previous study
reported a change of nearly 9% in VO2peak when participants in
the intervention group trained 5 times per week for 16 weeks
[70]. The subjects exercised under supervision once a week and
were encouraged to perform the remaining 4 sessions at home.
The endurance training was controlled by heart-rate
measurement [70]. In our study, a combination of the heart rate,
as an objective measure, and the Borg value, as a subjective
measure, were used to determine the intensity. Borg values are
considered an appropriate measure for monitoring and regulating
exercise intensity [34,71,72]. The results of this study, with a
short intervention period of 8 weeks, are consistent with those
of recent face-to-face research studies with respect to changes
in body composition and VO2peak, demonstrating the efficacy
of our eHealth approach [34,63,64,67,70,73]. For instance, in
a study by Keating et al (2015), the participants were supervised
and monitored using Borg values and heart rate during the
intervention period of 8 weeks [64]. Depending on the group
allocation, the participants were instructed to perform 2 or 3
sessions of aerobic exercise training a week; the exercise
quantity is comparable to that used in our study. With regard
to the exercise quality, Keating et al (2015) compared 3 different
training approaches in order to determine whether intensity or
volume is more effective [64]. A total of 47 obese adults trained
for 8 weeks with low-intensity and high-volume exercise,
high-intensity and low-volume exercise, or low-intensity and
low-volume exercise (or were prescribed a stretching and
self-massage program as placebo); all intervention groups
showed similar changes in VO2peak (by 2.29 [SD 0.77]
mL/kg/min, P<.01; 2.99 [SD 0.48] mL/kg/min, P<.01; and 2.24
[SD 0.54] mL/kg/min, P<.01, respectively), which is comparable
to our results. Therefore, the investigators concluded that volume
and intensity were both efficient [64]. However, with respect
to adherence, another study reported that high exercise frequency
is better accepted than high exercise intensity [74]. Furthermore,
high exercise intensity resulted in a higher percentage of
exercise-related injuries [74]. Despite the positive effects of
regular physical activity, independent of intensity and volume,
the most important challenge is adherence to exercise [75].
The Importance of Regular Support
Physical activity for 5 days per week is recommended for the
general population [58]. In addition, resistance training should
be performed at least 2 days a week. In contrast to the findings
of Perri et al [74], many study participants in this trial reported
that they struggled with integration of the demanding volume
in the second half of the intervention. Berzigotti et al (2016)
summarized the beneficial effects of exercise on the health of
patients with NAFLD, but also reported high dropout rates in
physical activity trials among these patients [3]. There is an
urgent need to counteract the sedentary habits of patients with
NAFLD. Despite the proven positive effects of regular physical
activity and a healthy diet, many people lack long-term
motivation [76]. Engaging in less physical activity increases
the risk of fatty changes in the liver [41,77,78]. In a previous
study, the physically inactive group showed a significantly
higher prevalence of fatty liver changes [78]. This finding is
supported by the results of a study by Perseghin et al (2007),
who showed an association between habitual physical activity
and intrahepatic fat content [79]. Furthermore, a large
cross-sectional study by Ryu et al (2015) fully supported this
finding: They showed that prolonged sitting times are positively
associated with the prevalence of NAFLD [42]. Therefore,
supporting patients to achieve and sustain regular activity is a
key issue in NAFLD management [12]. Due to the pronounced
sedentary lifestyle, starting with a low training volume and
intensity is recommended for motivational reasons. Self-chosen
sitting times should be reduced, and barriers for regular exercise
should be identified and eliminated [80]. Intensive-exercise
interventions carried out under supervision in hospitals or fitness
centers [32,34,68,70] impose an unnatural lifestyle on patients
for a short period of time. After the intervention, patients quickly
lose motivation and fall back into their old habits [45]. There
is a strong need and a high potential for Web-based intervention
designs [81,82]. Web-based interventions are essential to bridge
the treatment gap between demand and supply [83,84]. In a
previous study, patients with diabetes reported that they need
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a better strategy for transition to subsequent postintervention
conditions of less support [85]. Furthermore, from the patient’s
point of view, scheduling flexibility and geographical proximity
are important factors, which should be taken into account [85].
Even the most-powerful individualized exercise program
enhances the patient’s situation sustainably only if patients are
able to adopt the regular activity in their daily routine [86].
Therefore, the main focus is to incorporate an exercise program
into the daily routine of patients with NAFLD to promote
long-term changes [87] and reverse sedentariness [88]. Regular
feedback from a counselor seems to be an important aspect for
patients to stay motivated [89,90]. Furthermore, it is important
to integrate the patient in the decision-making process [86].
Thus, a change from compliance (implementation of
prescription) to adherence (mutual agreement between patient
and caregiver) should be achieved [82,86]. Growing interest in
utilization of modern technologies such as computers and
smartphones could encourage the use feasible ways to improve
knowledge and care in a home-based setting. Web-based support
allows a flexible scheduling of training and transfer of proper
guidance through regular counseling and tailored feedback. In
this study, common obstacles such as time constraints (eg, shift
work or family responsibilities) or no access to a fitness center
(eg, distance, high costs, or lack of sound advice) [37,43,45]
could be circumvented by using additional training equipment
like pulse watches and elastic bands. Furthermore, a regular,
close communication with a team of experts was achieved by
communication via the specially designed website. This
approach reduced the aforementioned geographical and
time-related barriers. In contrast to print-based interventions
and face-to-face counseling, Web-based communication reduces
costs and has a higher potential to reach a wide range of target
groups with tailored support [43,49,91]. Individualized
recommendations based on heart frequency and personal
feedback, expressed as rating of perceived exertion, seem to be
useful in this context [34].
This trial tests the feasibility of a Web-based exercise program
in a group of patients with liver disease. In line with the
recommendations of guidelines, this is also one of the first
investigations to support patients with NAFLD by providing a
combined endurance and strength training program.
Strengths and Limitations
This study has several strengths and limitations. The strengths
of this study include the performance of a liver biopsy, which
is the gold standard for diagnosing liver diseases [7,92].
Furthermore, this is the first Web-based approach for a tailored
exercise intervention in this patient group. In contrast to other
studies, we had only 1 (2.3%) dropout; our study showed good
adherence and tolerance in comparison to a recent review that
reported dropout rates of 6%-45% with a similar intervention
[75]. Possible advantages of the Web-based approach are the
flexible design and exercise implementation in the home
environment. This study had a few limitations. First,
investigators had to rely, at least partially, on subjective
feedback for training adherence without the possibility of visual
control by the sports physician. Data on training adherence
might be prone to social desirability bias as well as over- or
underestimation. Studies have previously discussed the issue
of over- or underestimation in home-based training settings
[93,94]. To reduce such potential bias, we combined the
subjective feedback (Borg rating for training sessions) with an
objective measurement (average heart rate). An individual who
tended to respond in a socially desirable fashion would need at
least some in-depth knowledge in exercise physiology to trick
the therapist or would most likely submit nonplausible data.
Second, this study lacked a control group. Because of different
comorbidities, some patients had to be excluded. Therefore, we
do not present a typical NAFLD collective here. Third, missing
features and confusing page layout of the website could have
affected user behavior. Most patients demanded regular
nutritional advice. Some of the participants stated that they
neglected their common eating habits due to diverse changes
during the intervention period (eg, marriage, job loss, or change
of shift). These changes could explain minor changes in the
weight status. Finally, the length of the intervention period (8
weeks) was probably too short to show further improvements
in weight status or cardiorespiratory fitness.
Conclusions
The present study indicates that 8 weeks of a Web-based, highly
individualized, supervised training is safe and feasible for
patients with NAFLD. The program significantly improved the
VO2peak and body composition. To influence the risk factor
sedentariness sustainably and enable a long-term lifestyle
change, an exercise program that can be integrated into everyday
life is needed. Web-based communication as a connection
between the patient and caregiver might be a useful and
cost-effective monitoring tool. Close contact with the supervisor
can immediately reduce sport-related doubts and anxieties as
well as motivational barriers. The Web-based design is the first
step to a new way of delivering services to patients with NAFLD
and potentially, other diseases. Future studies are required to
determine whether regular interaction between the patient and
the study team can be maintained in long-term. Additionally,
the intervention program presented here could be further
supplemented with individualized, nutritional advice by a
dietician to further improve the weight status. Finally, an expert
should rework the page design and integrate missing features
for a more pleasant experience with the webpage.
 
Acknowledgments
We thank all the participants of this study and the staff of the I. Department of Medicine, University Medical Center and the
Department of Sports Medicine, Rehabilitation and Disease Prevention at the Johannes Gutenberg University, Mainz, Germany,
for recruiting, sample processing, and support.
J Med Internet Res 2019 | vol. 21 | iss. 1 | e11250 | p.12http://www.jmir.org/2019/1/e11250/
(page number not for citation purposes)
Pfirrmann et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Authors' Contributions
PS, JMS, YH, and DP developed the individual study concepts. DP designed the website. PS and DP designed the exercise
components, and YH and JMS revised the manuscript. All authors read and approved the final document.
Conflicts of Interest
None declared.
Multimedia Appendix 1
Video clip of the Web-based exercise support concept.
[MP4 File (MP4 Video), 113MB - jmir_v21i1e11250_app1.mp4 ]
References
1. Finelli C, Tarantino G. Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?
World J Gastroenterol 2012 Dec 14;18(46):6790-6800 [FREE Full text] [doi: 10.3748/wjg.v18.i46.6790] [Medline:
23239917]
2. Gonçalves IO, Oliveira PJ, Ascensão A, Magalhães J. Exercise as a therapeutic tool to prevent mitochondrial degeneration
in nonalcoholic steatohepatitis. Eur J Clin Invest 2013 Nov;43(11):1184-1194. [doi: 10.1111/eci.12146] [Medline: 24033085]
3. Berzigotti A, Saran U, Dufour J. Physical activity and liver diseases. Hepatology 2016 Mar;63(3):1026-1040. [doi:
10.1002/hep.28132] [Medline: 26313307]
4. Whitsett M, VanWagner LB. Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review.
World J Hepatol 2015 Aug 08;7(16):2041-2052 [FREE Full text] [doi: 10.4254/wjh.v7.i16.2041] [Medline: 26261693]
5. Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol 2012
Apr;2(2):1143-1211 [FREE Full text] [doi: 10.1002/cphy.c110025] [Medline: 23798298]
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The
Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment
of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 May 16;285(19):2486-2497. [Medline:
11368702]
7. Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006 May;82(967):315-322 [FREE
Full text] [doi: 10.1136/pgmj.2005.042200] [Medline: 16679470]
8. Masarone M, Federico A, Abenavoli L, Loguercio C, Persico M. Non alcoholic fatty liver: epidemiology and natural history.
Rev Recent Clin Trials 2014;9(3):126-133. [Medline: 25514916]
9. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with
NAFLD and elevated liver enzymes. Hepatology 2006 Oct;44(4):865-873. [doi: 10.1002/hep.21327] [Medline: 17006923]
10. Wilkins T, Tadkod A, Hepburn I, Schade RR. Nonalcoholic fatty liver disease: diagnosis and management. Am Fam
Physician 2013 Jul 01;88(1):35-42 [FREE Full text] [Medline: 23939604]
11. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010
Dec;28(1):155-161. [doi: 10.1159/000282080] [Medline: 20460905]
12. Hallsworth K, Thoma C, Moore S, Ploetz T, Anstee QM, Taylor R, et al. Non-alcoholic fatty liver disease is associated
with higher levels of measured sedentary behaviour and lower levels of physical activity than matched healthy controls.
Frontline Gastroenterol 2015 Jan;6(1):44-51 [FREE Full text] [doi: 10.1136/flgastro-2014-100432] [Medline: 25580206]
13. Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol
2008 Jan;28(1):27-38 [FREE Full text] [doi: 10.1161/ATVBAHA.107.147538] [Medline: 17690317]
14. Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and
advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient
elastography. Gut 2012 Mar;61(3):409-415. [doi: 10.1136/gutjnl-2011-300342] [Medline: 21846782]
15. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in
an urban population in the United States: impact of ethnicity. Hepatology 2004 Dec;40(6):1387-1395. [doi:
10.1002/hep.20466] [Medline: 15565570]
16. Satapathy SK, Sanyal AJ. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2015
Aug;35(3):221-235. [doi: 10.1055/s-0035-1562943] [Medline: 26378640]
17. Koehler EM, Schouten JNL, Hansen BE, van RFJA, Hofman A, Stricker BH, et al. Prevalence and risk factors of
non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 2012 Dec;57(6):1305-1311.
[doi: 10.1016/j.jhep.2012.07.028] [Medline: 22871499]
18. Blachier M, Leleu H, Peck-Radosavljevic M, Valla D, Roudot-Thoraval F. The burden of liver disease in Europe: a review
of available epidemiological data. J Hepatol 2013 Mar;58(3):593-608 [FREE Full text] [doi: 10.1016/j.jhep.2012.12.005]
[Medline: 23419824]
J Med Internet Res 2019 | vol. 21 | iss. 1 | e11250 | p.13http://www.jmir.org/2019/1/e11250/
(page number not for citation purposes)
Pfirrmann et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
19. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002 Feb;17 Suppl:S186-S190. [Medline:
12000605]
20. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
Hepatology 2010 May;51(5):1820-1832. [doi: 10.1002/hep.23594] [Medline: 20432259]
21. Nobili V, Carter-Kent C, Feldstein AE. The role of lifestyle changes in the management of chronic liver disease. BMC Med
2011 Jun 06;9:70 [FREE Full text] [doi: 10.1186/1741-7015-9-70] [Medline: 21645344]
22. Berlanga A, Guiu-Jurado E, Porras JA, Auguet T. Molecular pathways in non-alcoholic fatty liver disease. Clin Exp
Gastroenterol 2014;7:221-239 [FREE Full text] [doi: 10.2147/CEG.S62831] [Medline: 25045276]
23. Ferreira DMS, Castro RE, Machado MV, Evangelista T, Silvestre A, Costa A, et al. Apoptosis and insulin resistance in
liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.
Diabetologia 2011 Jul;54(7):1788-1798. [doi: 10.1007/s00125-011-2130-8] [Medline: 21455726]
24. Adams LA, Lymp JF, St SJ, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver
disease: a population-based cohort study. Gastroenterology 2005 Jul;129(1):113-121. [Medline: 16012941]
25. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
J Hepatol 2008 Oct;49(4):608-612. [doi: 10.1016/j.jhep.2008.06.018] [Medline: 18682312]
26. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015 Jun 09;313(22):2263-2273. [doi:
10.1001/jama.2015.5370] [Medline: 26057287]
27. Newton JL, Jones DEJ, Henderson E, Kane L, Wilton K, Burt AD, et al. Fatigue in non-alcoholic fatty liver disease (NAFLD)
is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin
resistance. Gut 2008 Jun;57(6):807-813. [doi: 10.1136/gut.2007.139303] [Medline: 18270241]
28. Tomeno W, Kawashima K, Yoneda M, Saito S, Ogawa Y, Honda Y, et al. Non-alcoholic fatty liver disease comorbid with
major depressive disorder: The pathological features and poor therapeutic efficacy. J Gastroenterol Hepatol 2015
Jun;30(6):1009-1014. [doi: 10.1111/jgh.12897] [Medline: 25619308]
29. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver
disease: the impact of type and severity of disease. Am J Gastroenterol 2001 Jul;96(7):2199-2205. [doi:
10.1111/j.1572-0241.2001.03956.x] [Medline: 11467653]
30. Alt Y, Grimm A, Schlegel L, Grambihler A, Kittner JM, Wiltink J, et al. The Impact of Liver Cell Injury on Health-Related
Quality of Life in Patients with Chronic Liver Disease. PLoS One 2016;11(3):e0151200 [FREE Full text] [doi:
10.1371/journal.pone.0151200] [Medline: 26990427]
31. Al-Jiffri O, Al-Sharif FM, Abd El-Kader SM, Ashmawy EM. Weight reduction improves markers of hepatic function and
insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. Afr Health Sci 2013 Sep;13(3):667-672 [FREE
Full text] [doi: 10.4314/ahs.v13i3.21] [Medline: 24250305]
32. Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, et al. Both resistance training and aerobic training reduce
hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).
Hepatology 2013 Oct;58(4):1287-1295. [doi: 10.1002/hep.26393] [Medline: 23504926]
33. Hannah WN, Harrison SA. Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.
Dig Dis Sci 2016 May;61(5):1365-1374. [doi: 10.1007/s10620-016-4153-y] [Medline: 27052013]
34. Hallsworth K, Thoma C, Hollingsworth KG, Cassidy S, Anstee QM, Day CP, et al. Modified high-intensity interval training
reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci
(Lond) 2015 Dec;129(12):1097-1105. [doi: 10.1042/CS20150308] [Medline: 26265792]
35. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic
fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of
Gastroenterology, and the American Gastroenterological Association. Hepatology 2012 Jun;55(6):2005-2023. [doi:
10.1002/hep.25762] [Medline: 22488764]
36. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL
2009 special conference. J Hepatol 2010 Aug;53(2):372-384 [FREE Full text] [doi: 10.1016/j.jhep.2010.04.008] [Medline:
20494470]
37. Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle. A call
to action for clinicians. Arch Intern Med 2004 Feb 9;164(3):249-258. [doi: 10.1001/archinte.164.3.249] [Medline: 14769621]
38. Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, et al. Non-alcoholic fatty liver disease (NAFLD)
is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther 2012 Oct;36(8):772-781
[FREE Full text] [doi: 10.1111/apt.12038] [Medline: 22958053]
39. Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB. Health-related fitness and physical activity in patients with
nonalcoholic fatty liver disease. Hepatology 2008 Apr;47(4):1158-1166 [FREE Full text] [doi: 10.1002/hep.22137] [Medline:
18266250]
40. Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB, NASH CRN Research Group. Physical activity
recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011
Mar;106(3):460-8; quiz 469 [FREE Full text] [doi: 10.1038/ajg.2010.488] [Medline: 21206486]
J Med Internet Res 2019 | vol. 21 | iss. 1 | e11250 | p.14http://www.jmir.org/2019/1/e11250/
(page number not for citation purposes)
Pfirrmann et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
41. Wei H, Qu H, Wang H, Deng H. Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male
workers: a cross-sectional study. BMJ Open 2016 Dec 08;6(9):e011939 [FREE Full text] [doi: 10.1136/bmjopen-2016-011939]
[Medline: 27609847]
42. Ryu S, Chang Y, Jung H, Yun KE, Kwon M, Choi Y, et al. Relationship of sitting time and physical activity with
non-alcoholic fatty liver disease. J Hepatol 2015 Nov;63(5):1229-1237. [doi: 10.1016/j.jhep.2015.07.010] [Medline:
26385766]
43. Napolitano MA, Fotheringham M, Tate D, Sciamanna C, Leslie E, Owen N, et al. Evaluation of an internet-based physical
activity intervention: a preliminary investigation. Ann Behav Med 2003;25(2):92-99. [Medline: 12704010]
44. Thomas N, Alder E, Leese GP. Barriers to physical activity in patients with diabetes. Postgrad Med J 2004
May;80(943):287-291 [FREE Full text] [Medline: 15138320]
45. Centis E, Marzocchi R, Di DS, Ciaravella MF, Marchesini G. The effect of lifestyle changes in non-alcoholic fatty liver
disease. Dig Dis 2010;28(1):267-273. [doi: 10.1159/000282101] [Medline: 20460922]
46. Perrin A, Duggan M. Americans internet access - As internet use nears saturation for some groups, a look at patterns of
adoption. 2000. Pew Research Center URL: http://assets.pewresearch.org/wp-content/uploads/sites/14/2015/06/
2015-06-26_internet-usage-across-demographics-discover_FINAL.pdf [accessed 2018-06-11] [WebCite Cache ID
705lOu11M]
47. Fox, S. 2005. Health Information Online URL: http://www.pewinternet.org/files/old-media/Files/Reports/2005/
PIP_Healthtopics_May05.pdf.pdf [accessed 2018-06-11] [WebCite Cache ID 705lYT6wS]
48. Marcus BH, Nigg CR, Riebe D, Forsyth LH. Interactive communication strategies: implications for population-based
physical-activity promotion. Am J Prev Med 2000 Aug;19(2):121-126. [Medline: 10913903]
49. Williams DM, Matthews CE, Rutt C, Napolitano MA, Marcus BH. Interventions to increase walking behavior. Med Sci
Sports Exerc 2008 Jul;40(7 Suppl):S567-S573 [FREE Full text] [doi: 10.1249/MSS.0b013e31817c7006] [Medline: 18562974]
50. Frensham LJ, Zarnowiecki DM, Parfitt G, King S, Dollman J. The experiences of participants in an innovative online
resource designed to increase regular walking among rural cancer survivors: a qualitative pilot feasibility study. Support
Care Cancer 2014 Jul;22(7):1923-1929. [doi: 10.1007/s00520-014-2177-4] [Medline: 24573604]
51. Lee MK, Yun YH, Park H, Lee ES, Jung KH, Noh D. A Web-based self-management exercise and diet intervention for
breast cancer survivors: pilot randomized controlled trial. Int J Nurs Stud 2014 Dec;51(12):1557-1567. [doi:
10.1016/j.ijnurstu.2014.04.012] [Medline: 24856854]
52. Pfirrmann D, Tug S, Brosteanu O, Mehdorn M, Busse M, Grimminger PP, et al. Internet-based perioperative exercise
program in patients with Barrett's carcinoma scheduled for esophagectomy [iPEP - study] a prospective randomized-controlled
trial. BMC Cancer 2017 Jun 14;17(1):413 [FREE Full text] [doi: 10.1186/s12885-017-3400-8] [Medline: 28615010]
53. Pfirrmann D, Haller N, Huber Y, Jung P, Lieb K, Gockel I, et al. Applicability of a Web-Based, Individualized Exercise
Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process
Evaluation of 4 Ongoing Clinical Trials. JMIR Res Protoc 2018 May 22;7(5):e106 [FREE Full text] [doi:
10.2196/resprot.8607] [Medline: 29789277]
54. ACSM. In: Pescatello LS, Arena R, Riebe D, Thompson PD, editors. ACSM's Guidelines for Exercise Testing and
Prescription. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2013.
55. Wantland DJ, Portillo CJ, Holzemer WL, Slaughter R, McGhee EM. The effectiveness of Web-based vs. non-Web-based
interventions: a meta-analysis of behavioral change outcomes. J Med Internet Res 2004 Nov 10;6(4):e40 [FREE Full text]
[doi: 10.2196/jmir.6.4.e40] [Medline: 15631964]
56. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970;2(2):92-98. [Medline: 5523831]
57. Eysenbach G. The law of attrition. J Med Internet Res 2005 Mar 31;7(1):e11 [FREE Full text] [doi: 10.2196/jmir.7.1.e11]
[Medline: 15829473]
58. World Health Organization. Global Recommendations on Physical Activity for Health. World Health Organization 2010:1-60.
[Medline: 26180873]
59. Johnson NA, George J. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology
2010 Jul;52(1):370-381. [doi: 10.1002/hep.23711] [Medline: 20578153]
60. Cortez-Pinto H, Machado M. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Expert Rev
Gastroenterol Hepatol 2008 Apr;2(2):217-231. [doi: 10.1586/17474124.2.2.217] [Medline: 19072357]
61. Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects.
J Hepatol 1991 Mar;12(2):224-229. [Medline: 2051001]
62. Pugh CJA, Spring VS, Kemp GJ, Richardson P, Shojaee-Moradie F, Umpleby AM, et al. Exercise training reverses
endothelial dysfunction in nonalcoholic fatty liver disease. Am J Physiol Heart Circ Physiol 2014 Nov
01;307(9):H1298-H1306 [FREE Full text] [doi: 10.1152/ajpheart.00306.2014] [Medline: 25193471]
63. Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, et al. Resistance exercise reduces liver fat
and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011 Sep;60(9):1278-1283 [FREE
Full text] [doi: 10.1136/gut.2011.242073] [Medline: 21708823]
64. Keating SE, Hackett DA, Parker HM, O'Connor HT, Gerofi JA, Sainsbury A, et al. Effect of aerobic exercise training dose
on liver fat and visceral adiposity. J Hepatol 2015 Jul;63(1):174-182. [doi: 10.1016/j.jhep.2015.02.022] [Medline: 25863524]
J Med Internet Res 2019 | vol. 21 | iss. 1 | e11250 | p.15http://www.jmir.org/2019/1/e11250/
(page number not for citation purposes)
Pfirrmann et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
65. Levine JA, Eberhardt NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans.
Science 1999 Jan 08;283(5399):212-214 [FREE Full text] [Medline: 9880251]
66. Blair SN. Evidence for success of exercise in weight loss and control. Ann Intern Med 1993 Oct 01;119(7 Pt 2):702-706.
[Medline: 8363201]
67. Takahashi A, Abe K, Usami K, Imaizumi H, Hayashi M, Okai K, et al. Simple Resistance Exercise helps Patients with
Non-alcoholic Fatty Liver Disease. Int J Sports Med 2015 Oct;36(10):848-852. [doi: 10.1055/s-0035-1549853] [Medline:
26090879]
68. Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, Jones H, Pugh CJA, Richardson P, et al. Dissociation between
exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with
non-alcoholic fatty liver disease. Clin Sci (Lond) 2016 Jan;130(2):93-104. [doi: 10.1042/CS20150447] [Medline: 26424731]
69. Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, et al. Aerobic exercise training reduces
hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009 Oct;50(4):1105-1112. [doi:
10.1002/hep.23129] [Medline: 19637289]
70. Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride
content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 2012 Jun;55(6):1738-1745 [FREE Full text] [doi:
10.1002/hep.25548] [Medline: 22213436]
71. Dunbar CC, Robertson RJ, Baun R, Blandin MF, Metz K, Burdett R, et al. The validity of regulating exercise intensity by
ratings of perceived exertion. Med Sci Sports Exerc 1992 Jan;24(1):94-99. [Medline: 1549002]
72. Scherr J, Wolfarth B, Christle JW, Pressler A, Wagenpfeil S, Halle M. Associations between Borg's rating of perceived
exertion and physiological measures of exercise intensity. Eur J Appl Physiol 2013 Jan;113(1):147-155. [doi:
10.1007/s00421-012-2421-x] [Medline: 22615009]
73. Shamsoddini A, Sobhani V, Ghamar CME, Alavian SM, Zaree A. Effect of Aerobic and Resistance Exercise Training on
Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease. Hepat Mon 2015 Oct;15(10):e31434
[FREE Full text] [doi: 10.5812/hepatmon.31434] [Medline: 26587039]
74. Perri MG, Anton SD, Durning PE, Ketterson TU, Sydeman SJ, Berlant NE, et al. Adherence to exercise prescriptions:
effects of prescribing moderate versus higher levels of intensity and frequency. Health Psychol 2002 Sep;21(5):452-458.
[Medline: 12211512]
75. Golabi P, Locklear CT, Austin P, Afdhal S, Byrns M, Gerber L, et al. Effectiveness of exercise in hepatic fat mobilization
in non-alcoholic fatty liver disease: Systematic review. World J Gastroenterol 2016 Jul 21;22(27):6318-6327 [FREE Full
text] [doi: 10.3748/wjg.v22.i27.6318] [Medline: 27468220]
76. St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Independent effects of physical activity in patients with
nonalcoholic fatty liver disease. Hepatology 2009 Jul;50(1):68-76. [doi: 10.1002/hep.22940] [Medline: 19444870]
77. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Zvibel I, Goldiner I, et al. Role of leisure-time physical activity
in nonalcoholic fatty liver disease: a population-based study. Hepatology 2008 Dec;48(6):1791-1798. [doi: 10.1002/hep.22525]
[Medline: 18972405]
78. Hsieh SD, Yoshinaga H, Muto T, Sakurai Y. Regular physical activity and coronary risk factors in Japanese men. Circulation
1998 Feb 24;97(7):661-665 [FREE Full text] [Medline: 9495301]
79. Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A, et al. Habitual physical activity is associated with
intrahepatic fat content in humans. Diabetes Care 2007 Mar;30(3):683-688. [doi: 10.2337/dc06-2032] [Medline: 17327341]
80. Trenell MI. Sedentary behaviour, physical activity, and NAFLD: Curse of the chair. J Hepatol 2015 Nov;63(5):1064-1065.
[doi: 10.1016/j.jhep.2015.08.009] [Medline: 26297919]
81. Vandelanotte C, Sugiyama T, Gardiner P, Owen N. Associations of leisure-time internet and computer use with overweight
and obesity, physical activity and sedentary behaviors: cross-sectional study. J Med Internet Res 2009 Jul 27;11(3):e28
[FREE Full text] [doi: 10.2196/jmir.1084] [Medline: 19666455]
82. Montesi L, Moscatiello S, Malavolti M, Marzocchi R, Marchesini G. Physical activity for the prevention and treatment of
metabolic disorders. Intern Emerg Med 2013 Dec;8(8):655-666. [doi: 10.1007/s11739-013-0953-7] [Medline: 23657989]
83. Meyer B, Berger T, Caspar F, Beevers CG, Andersson G, Weiss M. Effectiveness of a novel integrative online treatment
for depression (Deprexis): randomized controlled trial. J Med Internet Res 2009;11(2):e15 [FREE Full text] [doi:
10.2196/jmir.1151] [Medline: 19632969]
84. Ritterband LM, Gonder-Frederick LA, Cox DJ, Clifton AD, West RW, Borowitz SM. Internet interventions: In review, in
use, and into the future. Professional Psychology: Research and Practice 2003;34(5):527-534. [doi:
10.1037/0735-7028.34.5.527]
85. Casey D, De Civita M, Dasgupta K. Understanding physical activity facilitators and barriers during and following a
supervised exercise programme in Type 2 diabetes: a qualitative study. Diabet Med 2010 Jan;27(1):79-84. [doi:
10.1111/j.1464-5491.2009.02873.x] [Medline: 20121893]
86. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee I, et al. American College of Sports Medicine
position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and
neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011
Jul;43(7):1334-1359. [doi: 10.1249/MSS.0b013e318213fefb] [Medline: 21694556]
J Med Internet Res 2019 | vol. 21 | iss. 1 | e11250 | p.16http://www.jmir.org/2019/1/e11250/
(page number not for citation purposes)
Pfirrmann et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
87. Johnson NA, Keating SE, George J. Exercise and the liver: implications for therapy in fatty liver disorders. Semin Liver
Dis 2012 Feb;32(1):65-79. [doi: 10.1055/s-0032-1306427] [Medline: 22418889]
88. Levine JA. Sick of sitting. Diabetologia 2015 Aug;58(8):1751-1758. [doi: 10.1007/s00125-015-3624-6] [Medline: 26003325]
89. Tate DF, Jackvony EH, Wing RR. A randomized trial comparing human e-mail counseling, computer-automated tailored
counseling, and no counseling in an Internet weight loss program. Arch Intern Med 2006;166(15):1620-1625. [doi:
10.1001/archinte.166.15.1620] [Medline: 16908795]
90. Kelders SM, Kok RN, Ossebaard HC, Van Gemert-Pijnen JEWC. Persuasive system design does matter: a systematic
review of adherence to web-based interventions. J Med Internet Res 2012;14(6):e152 [FREE Full text] [doi:
10.2196/jmir.2104] [Medline: 23151820]
91. Marcus BH, Lewis BA, Williams DM, Dunsiger S, Jakicic JM, Whiteley JA, et al. A comparison of Internet and print-based
physical activity interventions. Arch Intern Med 2007 May 14;167(9):944-949. [doi: 10.1001/archinte.167.9.944] [Medline:
17502536]
92. Afdhal NH. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver
disease: weight reduction, liver biopsy, or both? JAMA 2012 Aug 08;308(6):608-616. [doi: 10.1001/jama.2012.8402]
[Medline: 22760235]
93. Bantum EO, Albright CL, White KK, Berenberg JL, Layi G, Ritter PL, et al. Surviving and thriving with cancer using a
Web-based health behavior change intervention: randomized controlled trial. J Med Internet Res 2014;16(2):e54 [FREE
Full text] [doi: 10.2196/jmir.3020] [Medline: 24566820]
94. Hatchett A, Hallam JS, Ford MA. Evaluation of a social cognitive theory-based email intervention designed to influence
the physical activity of survivors of breast cancer. Psychooncology 2013 Apr;22(4):829-836. [doi: 10.1002/pon.3082]
[Medline: 22573338]
Abbreviations
BMI: body mass index
HELP: Hepatic Inflammation and Physical Performance in Patients With NASH
NAFLD: nonalcoholic fatty liver disease
NASH: nonalcoholic steatohepatitis
VO 2max: maximum volume of oxygen
VO 2peak: peak volume of oxygen
Edited by G Eysenbach; submitted 13.06.18; peer-reviewed by C Carrion, L Wesselman; comments to author 06.09.18; revised version
received 25.09.18; accepted 04.10.18; published 02.01.19
Please cite as:
Pfirrmann D, Huber Y, Schattenberg JM, Simon P
Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention
Study
J Med Internet Res 2019;21(1):e11250
URL: http://www.jmir.org/2019/1/e11250/ 
doi:10.2196/11250
PMID:30602434
©Daniel Pfirrmann, Yvonne Huber, Jörn Markus Schattenberg, Perikles Simon. Originally published in the Journal of Medical
Internet Research (http://www.jmir.org), 02.01.2019. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly
cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright
and license information must be included.
J Med Internet Res 2019 | vol. 21 | iss. 1 | e11250 | p.17http://www.jmir.org/2019/1/e11250/
(page number not for citation purposes)
Pfirrmann et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
